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reticulocytes parameters during nonsevere acute infection in pediatric outpatients
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Background/aim: This study aims to investigate the diagnostic utility of new erythrocytes, leukocytes, and reticulocytes parameters for
the identification of subclinical iron deficiency (ID) in children under 6 years with nonsevere acute infection in pediatric outpatients.
Materials and methods: The study included 102 children with acute infections and 31 true ID. Traditional and new hematology
parameters were measured in a Sysmex-XN®, along with C-reactive protein level, and iron parameters. Participants’ ID were categorized
as: the ferritin < 100 ng/mL, transferrin saturation < 20% was defined as “subclinical or functional ID (FID) in Group 1”; ferritin < 30
ng/mL, transferrin saturation < 20%, as “absolute-ID (AID)” in Group 2; ferritin < 12 ng/mL without anemia and infection, as “true ID”
in Group 3.
Results: The frequencies of FID and AID among the 102 children with acute infection were 24% and 76%, respectively. Compared with
the Group 2 patients, Group 1 had a significantly higher mean percentage of hypochromic erythrocytes (Hypo-He), and significantly
lower levels of hemoglobin (Hb) and Hb content of reticulocytes (RET-He) (p < 0.05 for all). Compared with Group 2 and Group 3
patients, Group 1 had a significantly higher mean percentage of immature reticulocyte fraction (IRF) and immature granulocyte (IG)
values (p < 0.05 for all). The RET-He, IRF%, Hypo-He%, and IG% cut-off values for predicting FID during infection were 27.0 pg,
10.6%, 2.5%, and 0.35% respectively.
Conclusion: The RET-He, Hypo-He, IRF, and IG may be useful parameters for identifying subclinical ID in small children with
nonsevere acute infection in pediatric outpatients.
Key words: Iron deficiency, child, infection

1. Introduction
Iron deficiency (ID) and iron deficiency anemia (IDA)
remain some of the major public health problems in the
world today [1]. A comprehensive study has reported
that the prevalence of ID and IDA in young children
were 32.5% and 7.8%, respectively [2]. Early diagnosis of
ID and the prompt initiation of iron therapy is primarily
important to the prevention of IDA in children [3,4].
Complete blood counts (CBCs) are widely used as one
of the most important tests for diagnosing acute infection
and IDA [5,6]. Modern hematology analyzers can now
reliably measure a broader panel of CBC parameters
including reticulocyte hemoglobin content (RET-He)
and hypochromic erythrocytes (Hypo-He), and these
can help discriminate functional or subclinical iron
deficiency (FID) from absolute iron deficiency (AID) in
the inflammatory phase of chronic disease, but data are

limited regarding the clinical utility of RET-He and HypoHe values for identifying ID/IDA in children with acute
inflammatory conditions such as acute infection [7–11].
In this study, we investigated the utility of new
erythrocytes, leukocytes, and reticulocytes parameters for
identifying subclinical ID in small children with nonsevere
acute infections in pediatric outpatient settings (POSs).
2. Methods
This cross-sectional study was approved by the Gazi
University Institutional Review Board. All parents
gave informed consent. The participants were children
between 6 months and 5 years of age who were assigned
ICD 10 codes “B34.9,” or “A49.9,” or “R50.9” for common
nonsevere infections and “E61.1” for ID upon admission
to our POSs during the winter months. Patients with
nonsevere acute infections were considered for enrollment
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if they met one or more inclusion criteria: i) presenting
complaint of fever; ii) clinically apparent infection recorded
as rhinosinusitis, acute otitis media, acute tonsillitis, or
pneumonia; iii) streptococcal pharyngitis or urinary tract
infection diagnosed by positive culture of throat or urine
sample; iv) antibiotic therapy administered based on the
clinician’s judgment. Healthy controls who were admitted
for preoperative evaluation were included. The exclusion
criteria were sepsis, anemia of chronic disease, immune
thrombocytopenic purpura (ITP), malignancy, and
hospitalization. Children who did not undergo iron status
or CRP testing were also excluded.
Of the 543 total patients screened, 133 were enrolled.
Hemogram with reticulocyte and conventional serum iron
parameters (serum iron [SI], total iron-binding capacity
[TIBC], and serum ferritin) and serum CRP level were
tested. Patients were assigned to the FID group (Group
1) and AID group (Group 2) and true ID group (Group
3) according to hemogram, CRP level, iron status. As
described previously, FID was defined as transferrin
saturation < 20% and ferritin < 100 ng/mL in association
with elevated CRP level, whereas AID was defined as
transferrin saturation < 20% and ferritin < 30 ng/mL in
association with normal CRP level during infection. True
ID was defined as ferritin < 12 ng/mL without anemia (Hb
>11gr/dL) and infection [1,4,12].
2.1. Hematological parameters and analyses
Serum iron level was photometrically measured on
AU5800 analyzer (Beckman Coulter, USA). Serum
ferritin was measured separately on the DXI800 analyzer
(Beckman Coulter, USA). Total iron-binding capacity is
a measure of plasma iron concentration as reflected by
plasma transferrin. Transferrin saturation was calculated
as SI divided by TIBC and expressed as a percentage.
Serum CRP level was measured using a nephelometric
assay (Beckman Instruments, California) with the normal
range specified as 0 to 6 mg/L.
Routine CBC parameters including hemoglobin (Hb),
mean corpuscular volume (MCV), mean corpuscular
hemoglobin (MCH), mean corpuscular Hb concentration
(MCHC), red blood cell (RBC) count, red cell distribution
volume (RDW), reticulocyte (RET) count, leukocyte count,
and counts and percentages of neutrophils, lymphocytes,
and monocytes and new CBC parameters were studied in
the Sysmex-XN® 2000 (Sysmex Corporation, Kobe, Japan).
Age- and gender-specific reference ranges for newer
CBC parameters and reticulocyte indices evaluated are
described below [13].
2.1.1. Reticulocyte parameters
Immature reticulocyte fraction (IRF) was the total
percentage of immature reticulocytes, calculated as the
sum of medium-fluorescent reticulocyte percentage (MFR)
plus high-fluorescent reticulocyte percentage (HFR).

Reticulocyte production index (RPI) was automatically
calculated as the following ratio: (reticulocyte percentage
[RET%] (×) hematocrit [HCT]) divided by (0.45 (×)
reticulocyte survival days in the blood), where 0.45
represents the ideal HCT. Other new reticulocyte-related
parameters analyzed were Hb content of reticulocytes
(RET-He in pg).
2.1.2. Erythrocyte parameters
The new erythrocyte parameters measured were percentage
hypochromic RBCs with Hb content < 17 pg (Hypo-He%);
percentage hyperchromic RBCs with Hb content > 49 pg
(Hyper-He%); percentage microcytic RBCs with volume
< 60 fL (Micro-R%); percentage macrocytic RBCs with
volume > 120 fL (Macro-R%).
2.1.3. Leukocyte parameters
The new leukocyte parameters measured were immature
granulocyte count (IG); high-fluorescent lymphocyte
count (HFLC).
2.2. Statistical analysis
All data were analyzed using SPSS 15.0. Results were
compared using the Mann-Whitney U test. Chi-square
testing was applied for categorical data. Spearman
correlation coefficient was used for the correlation analysis.
Receiver operating characteristic (ROC) analysis was
performed. P values <0.05 were considered statistically
significant.
3. Results
The demographic and clinical characteristics of the 133
patients are summarized in Table 1. The frequencies of FID
and AID among the 102 children with acute infection were
24% and 76%, respectively. The remaining 31 children
were diagnosed with true ID. There were no significant
differences between the groups with respect to age or sex
(p > 0.05 for both).
3.1. Infection types and treatment
The most common primary sites in order of frequency
were ear-nose-throat, urinary tract system, and lung in
Table 1. Compared with the Group 2 patients, Group 1 had
a significantly lower rate of ear-nose-throat infection, and
significantly higher rates of streptococcal pharyngitis, and
urinary tract infection (p < 0.05 for all). The mean values
for serum ferritin, ESR, and CRP levels were significantly
higher in Group 1 than in Group 2 and Group 3 (p < 0.05
for all). The rate of antibiotics in Group 1 was significantly
higher than that in Group 2 (p < 0.05).
3.2. Comparison of erythrocyte and reticulocyte
parameters
Data are summarized in Tables 2 and 3. Compared to
Group 2, Group 1 had significantly lower mean values for
serum Hb, RBC, and RET-He (p < 0.05 for both). Group
1 also had significantly higher mean values for Hypo-He
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Table 1. Demographic, clinical and laboratory characteristics of the 133 pediatric outpatients with/without nonsevere acute infections.

Variable

Group 1
n: 24

Group 2
n: 78

Group 3
n: 31

P1

P2

P3

Age (yrs)

2.6 ± 1.7

3.2 ± 1.5

2.9 ± 1.4

0.12

0.36

0.42

Males/Females

13 (55%)/
11 (45%)

42 (54%)/
36 (46%)

15 (48%)/
16 (52%)

0.98

0.67

0.76

Ear-nose-throat (otitis, tonsilitis, rhinosinusitis)

14 (58%)

71 (91%)

-

0.004

-

-

Pneumonia

1 (4%)

2 (3%)

-

0.88

-

-

Throat culture
(AGBHS)

5 (22%)

2 (2%)

-

0.007

-

-

Urine culture
(100,000 colonies E. coli, Klebsiella)

4 (16%)

3 (4%)

-

0.04

-

-

ESR (mm/h)

44.6 ± 6.2

15.1 ± 5.5

11.1 ± 1.7

0.001

0.15

CRP (mg/L)

48.5 ± 11.7

2.1 ± 0.1

1.1 ± 0.1

0.002
0.009

0.0001

0.96

0.28

0.12

Clinically documented infections

Microbiologically documented infections

Laboratory parameters

0.70

Serum iron (µg/dL)

56.3 ± 8.1

64.4 ± 5.1

39.8 ± 9.

SIBC (µg/dL)

310.9 ± 62.8

313.8 ± 53.1

362.8 ± 32.1

0.96

0.08

0.16

Ferritin (ng/mL)

74.3 ± 28.1

17.2 ± 4.9

8.2 ± 2.6

0.002

0.0001

0.01

14 (58%)

22 (25%)

-

0.005

-

-

Treatment
Antibiotic administered

Group 1: FID: functional iron deficiency; Group 2: AID: absolute iron deficiency; Group 3: True iron deficiency AGBHS: A group betahemolytic Streptococcus, ESR: Erythrocyte sedimentation rate, CRP: C-reactive protein, SIBC: Serum iron-binding capacity. p1: Group 1
vs. Group 2, p2: Group 1 vs. Group 3, p3: Group 2 vs. Group 3
Table 2. Comparison of erythrocytes parameters in the three groups of pediatric patients with/without acute infections.
Items

Group 1 (n:24)

Group 2 (n:78)

Group 3 (n:31)

P1

P2

P3

Hb (g/dl)

11.7 ± 0.3

12.5 ± 0.7

12.2 ± 0.4

0.001

0.07

0.25

RBC (1012/L)

4.6 ± 0.5

4.9 ± 0.4

4.8 ± 0.3

0.01

0.07

0.15

MCV (fl)

76.9 ± 6.4

77.3 ± 4.5

75.1 ± 6.9

0.09

0.79

0.06

MCH (pg)

26.5 ± 3.1

25.6 ± 2.2

25.4 ± 3.2

0.66

0.76

0.87

MCHC (g/dL)

32.5 ± 2.1

33.1 ± 1.3

32.7 ± 1.8

0.10

0.45

0.43

RDW (%)

14.7 ± 2.6

13.5 ± 2.1

14.4 ± 2.4

0.21

0.93

0.11

Micro-R (%)

16.7 ± 3.4

12.3 ± 1.2

18.5 ± 4.4

0.08

0.81

0.06

Macro-R (%)

3.5 ± 0.9

3.9 ± 0.5

3.6 ± 0.3

0.14

0.35

0.19

Hypo-He (%)

15.6 ± 4.6

4.4 ± 2.3

5.8 ± 3.2

0.04

0.23

0.35

Hyper-He (%)

0.3 ± 0.09

0.5 ± 0.1

0.3 ± 0.08

0.07

0.95

0.09

Micro-R: Microcytic-R, Macro-R: Macrocytic-R, Hypo-He: Hypochromic hemoglobin, HyperGroup 1: FID: Functional iron deficiency; Group 2: AID: Absolute iron deficiency; Group 3: True iron deficiency.
p1: Group 1 vs. Group 2, p2: Group 1 vs. Group 3, p3: Group 2 vs. Group 3
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than Group 2 (p < 0.05). Group 1 had significantly higher
mean values for IRF, MFR, HFR compared to Group 2 and
Group 3 (p < 0.05 for all).
3.3. Leukocytes parameters
Data are summarized in Table 4. Compared to Group 2
and Group 3, Group 1 had significantly higher mean values
for monocyte count, HFLC, IG, monocyte%, HFLC%, and
IG% (p < 0.05 for all). Compared to Group 3, Group 1 had
significantly higher mean values for leukocyte count (p <
0.05 for all).
3.4. Correlation of leukocyte parameters and CRP level
The IG (%) (r = 0.72, p: 0.0001) and IG count (r = 0.68, p:
0.0001) were positive moderately correlated with CRP in
Group 1.

3.5. Receiver operating characteristic analysis
The results of ROC analysis for identifying subclinical ID
or FID are shown in Figures 1a, 1b, 2 and 3. Regarding
erythrocytes and reticulocyte parameters, the established
area under the curve (AUC) cut-off values were 10.6%
for IRF, 9.2% for MFR, 1.4% for HFR, 2.5% for Hypo-He,
and 27.0 pg for RET-He. Sensitivity was highest for IRF
(80%; 95% confidence interval [CI] 70%–89%) and HFR
(81%; 95%CI 71%–89%) followed by MFR (79%; 95%CI
68%–88%) RET-He (64%; 95% CI 31%–88%) and HypoHe (62%;95%CI 36%–81%). Specificity was highest for
RET-He (96%; 95% confidence interval [CI] 78%–99%)
and Hypo-He (88%; 95%CI 70%–98%) followed by IRF
(71%; 95%CI 57%–82%) MFR (70%; 95% CI 57%–80%)

Table 3. Comparison of reticulocytes parameters in the three groups of pediatric patients with/without acute infections.
Items

Group 1 (n:24)

Group 2 (n:78)

Group 3 (n:31)

P1

P2

P3

23.5 ± 2.8

29.1 ± 0.9

28.8 ± 1.9

0.02

0.17

0.77

RET (10 /L)

52.7 ± 9.7

54.7 ± 4.6

52.4 ± 9.1

0.86

0.81

0.08

RET (%)

1.1 ± 0.3

1.2 ± 0.4

1.0 ± 0.2

0.88

0.15

0.09

RPI (%)

0.5 ± 0.1

0.7 ± 0.3

0.5 ± 0.2

0.26

0.53

0.20

IRF (%)

15.8 ± 1.2

11.1 ± 1.3

9.1 ± 1.6

0.02

0.01

0.45

MFR (%)

12.1 ± 1.1

8.9 ± 0.7

8.1 ± 3.1

0.03

0.02

0.64

HFR (%)

3.9 ± 1.0

2.2 ± 0.6

0.9 ± 0.3

0.04

0.03

0.40

RET-He
12

IRF: Immature reticulocyte fraction; MFR: Medium-fluorescent reticulocyte percentage; HFR: High fluorescent reticulocyte percentage,
RPI: Reticulocyte production index, RET-He: Hemoglobin content of the reticulocytes,
Group 1: FID: Functional iron deficiency; Group 2: AID: Absolute iron deficiency; Group 3: True iron deficiency.
p1: Group 1 vs. Group 2, p2: Group 1 vs. Group 3, p3: Group 2 vs. Group 3
Table 4. Comparison of leukocytes parameters in the three groups of pediatric patients with/without acute infections.
Items

Group 1 (n:24)

Group 2 (n:78)

Group 3 (n:31)

P1

P2

P3

Leukocyte (10 /L)

9.8 ± 3.3

8.9 ± 2.7

8.1 ± 1.9

0.20

0.04

0.27

Neutrophil (%)

37.9 ± 19.7

37.2 ± 13.9

34.3 ± 10.5

0.86

0.67

0.24

Neutrophil (109/L)

4.1 ± 2.8

3.4 ± 1.7

2.7 ± 1.1

0.78

0.21

0.11

Lymphocyte (%)

49.5 ± 18.2

50.5 ± 13.6

54.8 ± 10.4

0.92

0.45

0.14

Lymphocyte (109/L)

4.6 ± 2.2

4.4 ± 1.7

4.5 ± 1.5

0.88

0.77

0.82

Monocyte (%)

10.6 ± 5.5

7.9 ± 3.3

8.1 ± 2.4

0.03

0.04

0.28

Monocyte (109/L)

1.0 ± 0.5

0.7 ± 0.3

0.6 ± 0.2

0.005

0.007

0.82

IG (%)

0.4 ± 0.03

0.3 ± 0.02

0.2 ± 0.03

0.04

0.03

0.44

IG (10 /L)

0.04 ± 0.006

0.03 ± 0.002

0.02 ± 0.002

0.03

0.01

0.26

HFLC (%)

1.1 ± 0.1

0.5 ± 0.03

0.4 ± 0.03

0.003

0.002

0.68

HFLC (10 /L)

0.09 ± 0.008

0.04 ± 0.002

0.03 ± 0.002

0.001

0.001

0.37

9

9

9

He: Hyperchromic hemoglobin, IG: Immature granulocyte,
Group 1: FID: Functional iron deficiency; Group 2: AID: Absolute iron deficiency; Group 3: True iron deficiency.
p1: Group 1 vs. Group 2, p2: Group 1 vs. Group 3, p3: Group 2 vs. Group 3
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Figure 1a. Hb content of reticulocytes (RET-He) index for identifying subclinical iron deficiency
in children with acute infections. Figure 1b. Receiver operating characteristic curve analysis of
hypochromic erythrocytes (Hypo-He).
IG: immature granulocyte, AUC: area under curve, CI: confidence interval

Figure 2. Receiver operating characteristic curve analysis of
immature reticulocyte fraction (IRF), medium-fluorescent
reticulocyte percentage (MFR) and high-fluorescent reticulocyte
percentage (HFR) for identifying subclinical iron deficiency in
children with acute infections.
IRF: Immature reticulocyte fraction, MFR: Medium-florescent
reticulocyte, HFR: High-florescent reticulocyte, AUC: Area
under curve, CI: Confidence interval
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Figure 3. Receiver operating characteristic curve analysis of
immature granulocyte parameters for identifying subclinical
iron deficiency in children with acute infections.
IG: Immature granulocyte, AUC: Area under curve, CI:
Confidence interval
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and HFR (72%;95%CI 58%–83%). Regarding leukocyte
parameters, the established area under the curve (AUC)
cut-off values were 0.03 (x) 109/L for IG, and 0.35%
for IG%. Sensitivity was higher for IG% (82%; 95%CI
71%–90%) compared with IG (71%; 95%CI 59%–81%).
Specificity was also higher for IG (80%; 95%CI 75%–85%)
compared with IG% (70%; 95%CI 65%–75%).
4. Discussion
In this study, we found the subclinical ID or FID frequency
of (24%) and the AID frequency of (76%) among 102
children less than 6 years old with nonsevere acute
infection in POSs. Similarly, the literature indicates a wide
range of FID incidence, from 13% to 90%, in children with
the inflammatory phase of chronic conditions [14–16].
During the acute infection or the inflammatory phase of
chronic disease, serum iron and ferritin are increased,
whereas transferrin is decreased. This means that iron
parameters are less reliable markers for diagnosing ID
in these conditions. Serum transferrin receptor level
and hepcidin may be useful for distinguishing anemia
of inflammation from iron deficiency anemia (IDA), but
these tests are not widely available [17]. Previous authors
have documented the use of new red cell parameters in
hematology analyzers for discriminating between FID and
AID in the inflammatory phase of chronic disease [14–16].
Absolute and true ID have been well described in children
less than 6 years old according to the World Health
Organization guideline, but recognizing FID during acute
infection can be challenging [1].
Functional iron deficiency is a major component of
anemia of chronic disease [14–16]. It is most commonly
identified as normocytic or normochromic anemia, but
can become microcytic and hypochromic as the disease
progresses. Reticulocytosis is not usually observed. The
recent development of automated RET counts has allowed
the more precise counting of these cells, as well as an
objective measure of their maturity based on RNA content
[7,18]. New reticulocyte and erythrocyte parameters, such
as RET-He, RPI, IRF, Micro-R, and Hypo-He, are useful
parameters for evaluating erythropoietic activity in FID
[19]. Of these, RET-He (< 25pg) and the percentage of
hypochromic red cells (≥ 6%) have been incorporated into
the revised guidelines associated with anemia of chronic
disease [12]. Similarly, in the initial phase of infection,
ID can be mild to moderate, and if it goes unrecognized,
the child may develop anemia. Using the RET-He and
Hypo-He, physicians can identify ID before IDA develops.
Reticulocyte Hb content is an early and sensitive marker
of iron-restricted erythropoiesis in FID, whereas the
proportion of hypochromic red cells is a time-averaged
marker. Both these indices are similar in anemic patients,
as are glucose and HbA1C in diabetic patients. In accord

with these data, we identified subclinical ID with high
specificity, moderate sensitivity, and diagnostic values of
RET-He and Hypo-He in children with nonsevere acute
infections. Advanced red cell parameters such as RETHe and Hypo-He are useful parameters for identifying
subclinical ID in children with nonsevere acute infections
because RET-He is not influenced by acute phase response
[20].
Automated counting of reticulocytes enabled the
introduction of the new reticulocyte parameter IRF [7,18].
This value is thought to be more sensitive than absolute
or corrected RET counts for detecting recovery of bone
marrow function. A finding of increased IRF during ID
indicates that MFR and/or HFR is high. This suggests
that IRF could potentially be an early diagnostic marker
for IDA. Many researchers have reported data related to
the clinical utility of IRF, MFR, and HFR in diagnosing
and monitoring different types of anemia [7,21–23]. The
IRF increases earlier than RET count, and therefore can
be useful for monitoring the efficacy of therapy in IDA.
In situations where erythropoiesis is ineffective, IRF is
also increased while RET count is reduced or normal, as
demonstrated in some cases with acute infections. In one
study, the mean MFR and HFR in children with IDA were
10.3% and 2.3%, respectively [23]. Similarly, in our study,
we identified cut-off values for predicting FID as 10.6% for
IRF, 9.2% for MFR, and 1.4% for HFR. These values closely
matched the means of 10.7% for IRF, 9.2% for MFR, and
1.5% for HFR that were reported for anemia of acute
infection in children from Seoul, Korea [7]. Our findings
indicate that these markers are moderately sensitive and
specific markers for distinguishing FID from AID during
infections in children who present POSs. However, the
reliability of the IRF determination has been questioned
because it is based on a very small number of counted
cells. The gating for the HFR fraction is such that it is
extremely susceptible to interference from other cellular
blood elements, primarily leukocytes or large platelets.
Some of these cells tend to enter the gating area selected
for IRF determination, and will be falsely counted as part
of the HFR value [18]. Therefore, we excluded patients
with sepsis, ITP, and malignancy to prevent interference
with large platelet and high leukocyte counts. Regardless,
IRF is a promising parameter that needs to be part of
assessments in clinical practice, especially acute infections.
The earliest elevated marker during infection is CRP
[24]. As an acute-phase protein, raised CRP level is often a
useful sign of an acute infection or the acute exacerbation
of chronic disease [14,25]. Thus, the rapid availability
of CBC and CRP results could provide a considerable
advantage for diagnosing children with acute infections.
We observed higher mean values for HFLC and IG
values in the FID Group. Several observations have been
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reported for severe bacterial infections in children, while
a relationship between IG and nonsevere infections has
only been reported in only one comprehensive study of
children in POSs as confirmed here [8,26,27]. This study
suggested that the threshold 0.04 (x) 109/L for IG and
0.3% in children younger than 10 years could be useful
tools for identifying common acute infections in POSs [7].
Similarly, we found IG and IG% to be highly sensitive and
specific for predicting FID in children less than 6 years
old. Our cut-off levels were 0.03 (x) 109/L for IG and 0.35%
for IG%, respectively. In addition, statistically significant,
moderately sized correlations were demonstrated between
CRP level and IG values in the present study. Our results
suggest that similar to CRP, IG could be a useful adjunctive
marker for identifying FID in children with acute infection.
Several inflammatory markers, including leukocyte
populations and validated CRP levels, should enable
physicians to reliably identify children who need antibiotic
treatment and help avoid treating those with viral disease
[24,25]. One study showed that the antibiotic prescription
rate was 56% higher for children with elevated CRP
compared to those with normal CRP levels, thus this
approach was indicated to prevent unnecessary antibiotic
use in POS [24]. Another study revealed that of all febrile
children with elevated CRP who were prescribed antibiotics

in a POS, only 62% actually had bacterial infections [25].
In our study, we observed a similar antibiotic prescription
rate (58%) based on a clinical and laboratory finding of
elevated CRP, increased IG counts, and positive culture in
febrile pediatric outpatients.
The first limitation of this study was that iron status
and hemostatic testing were not repeated after recovery to
confirm whether ID was restricted to the infection period.
The second limitation was that all nonculture and culturebased tests were not performed to distinguish between
viral and bacterial infections in POSs. The third limitation
was the small sample size.
Our data indicate that RET-He, Hypo-He, IRF, and
IG in addition to conventional iron parameters may be
useful parameters for the early detection of subtle ID in
children under 6 years with nonsevere acute infections
at POS.
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